ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityActive in the last 2 years
Wei‐Ming Wang
Matched on ORCID iD 0000-0002-6493-1811; OpenAlex author ID A5100342176. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers
Papers 4
- Bulk anda single-cell transcriptome profiling reveals the molecular characteristics of T cell-mediated tumor killing in pancreatic cancer. Last author DOI 10.1016/j.heliyon.2024.e27216↗
- BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis. Co-author DOI 10.3390/cancers16081540↗
- Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling. First author DOI 10.1016/j.phymed.2021.153861↗
- Dipeptidyl Peptidase-4 modulates Long-chain Acyl-CoA synthetase 4 to Promote Lipid Peroxidation and Regulate Ferroptosis in Pancreatic Cancer First author DOI 10.21203/rs.3.rs-173980/v1↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiang Zhou · 2 shared papers, 2022–2024 · strength 0.43
- Gang Chen · 2 shared papers, 2021–2024 · strength 0.40
- Zhenyan Pan · 1 shared paper, 2024 · strength 0.28
- Lingming Kong · 1 shared paper, 2024 · strength 0.28
- Xiang Zhou · 1 shared paper, 2024 · strength 0.26
- Yinwei Dai · 1 shared paper, 2024 · strength 0.26
- Xu Zheng · 1 shared paper, 2022 · strength 0.15
- Chunmei Wen · 1 shared paper, 2022 · strength 0.15
- Jie Deng · 1 shared paper, 2022 · strength 0.15
- Qingqing Ruan · 1 shared paper, 2022 · strength 0.15
- Yongheng Bai · 1 shared paper, 2022 · strength 0.15
- Yi Wang · 1 shared paper, 2021 · strength 0.12
- Xiang Zhou · 1 shared paper, 2021 · strength 0.12
- Jiuyi Zheng · 1 shared paper, 2021 · strength 0.12
- Yunfeng Shan · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.